Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

NCT05183035 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Fludarabine
DRUG: Cytarabine
DRUG: Gemtuzumab Ozogamicin
DRUG: Azacitidine
DRUG: Venetoclax

Sponsor

PedAL BCU, LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]